Clinical Report: First Year of Regulated Psilocybin Services in Oregon
Overview
The inaugural year of the Oregon Psilocybin Services program saw 5,935 clients participate in 5,375 sessions, with significant service tourism and a predominance of midlife adults. Adverse events were rare, highlighting the program's safety profile amidst ongoing discussions about equity and access.
Background
The Oregon Psilocybin Services Act established the first state-regulated framework for psilocybin in the U.S., allowing supervised administration for adults. Understanding client demographics and motivations is crucial for informing policy and ensuring equitable access to these services. This analysis provides essential insights into the utilization patterns and safety of psilocybin services in a non-medical context.
Data Highlights
Metric
Value
Clients
5,935
Sessions
5,375
Peak Participation (Q2)
1,758
Women Participants
57.4%
Adverse Events (Behavioral)
2.42 per 1,000 sessions
Adverse Events (Medical)
2.79 per 1,000 sessions
Key Findings
5,935 clients participated in 5,375 psilocybin sessions in 2025.
32.6% of participants were from outside Oregon, indicating significant service tourism.
Approximately 40% of clients were aged 35–49, with 57.4% identifying as women.
Racial diversity was limited, with 84.1%–91.5% of participants being White.
Adverse events were rare, with rates of 2.42 behavioral and 2.79 medical events per 1,000 sessions.
Clinical Implications
The findings suggest that psilocybin services are being utilized primarily by midlife adults, with a notable representation of sexual and gender minorities. However, the racial disparities in participation highlight the need for targeted outreach and policy adjustments to ensure equitable access to these services.
Conclusion
The first year of the Oregon Psilocybin Services program demonstrates a stable utilization pattern and a favorable safety profile, while also revealing important demographic trends that warrant further attention in policy discussions.
